Zhuhai Trinomab Pharmaceutical Co., Ltd. (SHA:688806)

China · Delayed Price · Currency is CNY

25.90

+2.06 (8.64%)

At close: Aug 4, 2026

SHA:688806 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	75.98	51.22	15.06	-	4.34
Revenue Growth	1650.88%	240.23%	-	-	-
Gross Profit	38.13	22.29	-0.23	-	1.56
Operating Income	-507.21	-595.22	-517.82	-467.79	-367.54
Net Income	-520.98	-601.32	-514.77	-446.46	-428.67
Earnings Per Share	-1.33	-1.56	-1.42	-1.42	-2.68
EPS Growth	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Investments	475.3	515.37	559.41	625.53	758.35
Total Debt	779.97	695.91	402.27	203.64	119.5
Net Cash (Debt)	-304.67	-180.53	157.14	421.9	638.86
Net Cash Growth	-	-	-62.75%	-33.96%	-
Net Cash Per Share	-0.78	-0.47	0.43	1.34	3.99

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Cash Flow	-509.44	-580.01	-369.29	-309.09	-302.49
Capital Expenditures	-23.12	-22.35	-16.26	-20.86	-60.35
Free Cash Flow	-532.56	-602.36	-385.55	-329.96	-362.84
Free Cash Flow Growth	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Gross Margin	50.18%	43.51%	-1.50%	-	35.95%
Operating Margin	-667.52%	-1161.98%	-3439.31%	-	-8469.02%
Pretax Margin	-685.87%	-1174.00%	-3419.05%	-	-9877.68%
Profit Margin	-685.64%	-1173.88%	-3419.05%	-	-9877.67%
FCF Margin	-700.88%	-1175.92%	-2560.78%	-	-8360.75%